-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Biocryst Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2013 to 2023.
- Biocryst Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 207M shares, a 9.1% increase year-over-year.
- Biocryst Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 192M shares, a 3.38% increase from 2022.
- Biocryst Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 186M shares, a 3.79% increase from 2021.
- Biocryst Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 179M shares, a 7.08% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)